메뉴 건너뛰기




Volumn 102, Issue 21, 2005, Pages 7665-7670

Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib

Author keywords

Drug resistance; Molecular targeted therapy; Non small cell lung cancer; Tyrosine kinase inhibitor

Indexed keywords

ANILINOQUINAZOLINE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ERLOTINIB; GEFITINIB; HKI 272; HKI 357; MUTANT PROTEIN; PELITINIB; PROTEIN TYROSINE KINASE; QUINAZOLINE DERIVATIVE; UNCLASSIFIED DRUG;

EID: 21144439000     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0502860102     Document Type: Article
Times cited : (888)

References (27)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.